NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes

AIMS: We aimed to determine whether NeuroD1/BETA2 and PAX4 polymorphisms were associated with the therapeutic efficacy of repaglinide in Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: Three hundred and sixty-eight T2DM patients and 132 healthy control subjects were genotyped by restricti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gong, Zhi-Cheng, Huang, Qiong, Dai, Xing-Ping, Lei, Guang-Hua, Lu, Hong-Bin, Yin, Ji-Ye, Xu, Xiao-Jing, Qu, Jian, Pei, Qi, Dong, Min, Zhou, Bo-Ting, Shen, Jie, Zhou, Gan, Zhou, Hong-Hao, Liu, Zhao-Qian
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Science Inc 2012
Soggetti:
Pharmacogenetics
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3477351/
https://ncbi.nlm.nih.gov/pubmed/22296034
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04202.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi